前的吸烟作为视野进展的危险因素,在瑞典脱皮绿内障患者
1Eye Department, Skaraborg Hospital, Sahlgrenska Academy, Gothenburg University & Karolinska Institute, Skövde, Sweden.
European journal of ophthalmology
|January 17, 2024
概括
前吸烟显著加速视野进展在脱皮绿内障患者. 医疗保健提供者应该考虑吸烟状况,并为前吸烟者提供增强的护理,以有效管理青光眼.
科学领域:
- 眼科医生 眼科 眼科
- 玻璃眼研究研究 玻璃眼研究
- 公共卫生 公共卫生
背景情况:
- 脱皮绿内障是一种常见的开角绿内障的亚型.
- 视野进展是青光眼严重程度的关键指标,影响患者的预后.
- 吸烟作为青光眼进展的危险因素的作用是正在进行的调查领域.
研究的目的:
- 为了确定以前的吸烟是否是患有脱皮绿内障的患者视野进展的危险因素.
- 为了评估吸烟状态和青光眼恶化的速度之间的关联.
主要方法:
- 一项前性非随机队列研究,包括113名脱皮绿内障患者.
- 使用汉弗里场分析仪 (24-2测试) 评估了至少五个可靠的视野,进行了为期三年的随访.
- 使用平均偏差 (MD),进展率 (ROP) 和指导进展分析 (GPA) 分析视野进展.
主要成果:
- 在所有三种分析模型 (MD,ROP,GPA;p ≤0.01) 中,吸烟是视野进展的重要预测因素.
- 即使在调整眼内压力 (IOP) 之后,这种关联仍然很重要.
- 其他确定的预测因素包括诊断时的IOP,选择性激光轨道造形术 (SLT) 治疗和药物数量.
结论:
- 前的吸烟显著导致视野恶化在脱皮绿内障.
- 吸烟状况是一个关键因素,在青光眼的诊断和管理过程中需要考虑.
- 前吸烟者患有脱皮光眼可能需要加强监测和护理,以减轻疾病的进展.
相关概念视频
Photoreceptors and Visual Pathways
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...


